Gynecological Cancer
📧 Sign up to get email alerts when something new happens for Gynecological Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-12-27Clinical Trial Update: A Phase II Study of Anlotinib Combined With Penpulimab in Subjects With Gynecological Cancer [Phase 2]
Phase II study evaluating anlotinib combined with penpulimab in gynecological cancer is in early results with unknown current status.
-
CLINICAL_TRIALS trial_result · 2021-01-12Clinical Trial Update: A Study of TQB2450 Combined With Anlotinib in Subjects With Gynecological Cancer [Phase 1, Phase 2]
A clinical trial evaluating TQB2450 in combination with Anlotinib in gynecological cancer across Phase 1 and Phase 2 stages; current status …
-
CLINICAL_TRIALS trial_result · 2020-03-20Clinical Trial Update: Phase I Study of Lurbinectedin (PM01183) in Combination With Paclitaxel, With or Without Bevacizumab, in Selected Advanced Solid Tumors [Phase 1]
Phase I study of lurbinectedin in combination with paclitaxel, with or without bevacizumab, in selected advanced solid tumors (completed; re…
-
CLINICAL_TRIALS trial_result · 2019-09-11Clinical Trial Update: Recovery and Analgesia After Surgery for Gynecological Cancer [Phase 4]
Phase 4 clinical trial update on recovery and analgesia after gynecologic cancer surgery; results posted. Completed study.